Market Price

60.90 

-0.95 -1.5%

as of Oct 23 '18

52 Week Range:

59.20 80.25


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for medicines and cosmetics, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Nov '07 Nov '08 Nov '09 Nov '10 Nov '11 Nov '12 Nov '13 Nov '14 Nov '15 Nov '16 Nov '17
Equity (BVPS) 14.84
14.84
14.12
15.56
16.29
17.04
14.90
16.76
17.35
20.81
22.76
growth rate 0.0% -4.9% 10.2% 4.7% 4.6% -12.6% 12.5% 3.5% 19.9% 9.4%
Earnings BIT -24.25
17.30
20.12
60.70
72.52
95.75
140.17
139.74
141.18
176.21
172.27
growth rate 100.0% 16.3% 201.7% 19.5% 32.0% 46.4% -0.3% 1.0% 24.8% -2.2%
Avg.PE -854.80
1,111.11
125.00
20.49
19.38
20.58
25.06
23.51
28.93
17.40
19.57
growth rate 100.0% -88.8% -83.6% -5.4% 6.2% 21.8% -6.2% 23.1% -39.9% 12.5%
ROA -0.10
0.05
0.40
3.20
3.52
3.92
3.92
4.06
5.11
5.07
4.19
growth rate 100.0% 700.0% 700.0% 10.0% 11.4% 0.0% 3.6% 25.9% -0.8% -17.4%
ROE -0.57
0.16
1.31
9.27
10.10
11.50
11.94
12.64
17.82
17.99
13.64
growth rate 100.0% 718.8% 607.6% 9.0% 13.9% 3.8% 5.9% 41.0% 1.0% -24.2%
ROIC -1.49
8.41
9.12
14.95
15.62
6.10
8.67
8.83
9.82
8.84
7.25
growth rate 100.0% 8.4% 63.9% 4.5% -61.0% 42.1% 1.9% 11.2% -10.0% -18.0%
Cur. Ratio 1.42
1.10
0.99
1.08
1.44
1.33
1.12
1.10
0.80
1.00
1.06
growth rate -22.5% -10.0% 9.1% 33.3% -7.6% -15.8% -1.8% -27.3% 25.0% 6.0%
Quick Ratio 0.83
0.62
0.61
0.67
0.94
0.81
0.63
0.63
0.49
0.68
0.82
growth rate -25.3% -1.6% 9.8% 40.3% -13.8% -22.2% 0.0% -22.2% 38.8% 20.6%
Leverage 3.09
3.54
3.02
2.78
2.96
2.91
3.19
3.05
3.86
3.27
3.25
growth rate 14.6% -14.7% -8.0% 6.5% -1.7% 9.6% -4.4% 26.6% -15.3% -0.6%
Balance Sheet Nov '07 Nov '08 Nov '09 Nov '10 Nov '11 Nov '12 Nov '13 Nov '14 Nov '15 Nov '16 Nov '17
Acct.Receivable 142.98
135.36
154.00
177.00
206.00
215.33
235.97
253.25
261.18
268.16
growth rate -5.3% 13.8% 14.9% 16.4% 4.5% 9.6% 7.3% 3.1% 2.7%
Acct.Payable 111.00
119.00
154.00
127.04
125.48
160.94
157.00
176.30
growth rate 7.2% 29.4% -17.5% -1.2% 28.3% -2.5% 12.3%
Cur.Assets 457.03
335.58
365.00
478.00
485.00
487.02
502.17
538.10
542.71
715.21
growth rate -26.6% 8.8% 31.0% 1.5% 0.4% 3.1% 7.2% 0.9% 31.8%
Total Assets 1,515.00
1,340.60
1,358.00
1,515.00
1,556.00
1,615.77
1,655.93
2,419.45
2,374.26
2,444.10
growth rate -11.5% 1.3% 11.6% 2.7% 3.8% 2.5% 46.1% -1.9% 2.9%
Cash 94.40
56.10
61.00
131.00
86.00
73.09
67.94
93.67
118.39
287.04
growth rate -40.6% 8.7% 114.8% -34.4% -15.0% -7.1% 37.9% 26.4% 142.5%
Inventory 154.06
125.81
138.00
160.00
189.00
194.46
193.67
186.39
155.43
148.36
growth rate -18.3% 9.7% 15.9% 18.1% 2.9% -0.4% -3.8% -16.6% -4.6%
Cur.Liabilities 416.44
338.78
337.00
333.00
364.00
433.56
455.81
667.75
541.06
673.34
growth rate -18.7% -0.5% -1.2% 9.3% 19.1% 5.1% 46.5% -19.0% 24.5%
Liabilities 1,035.90
897.20
828.00
963.00
1,018.00
1,052.36
1,051.56
1,721.31
1,610.96
1,654.57
growth rate -13.4% -7.7% 16.3% 5.7% 3.4% -0.1% 63.7% -6.4% 2.7%
LT Debt 415.81
402.92
0.00
303.00
442.00
410.00
384.05
365.59
722.29
723.13
673.86
growth rate -3.1% -100.0% 45.9% -7.2% -6.3% -4.8% 97.6% 0.1% -6.8%
Equity 465.36
479.10
480.20
529.40
552.20
538.20
505.89
543.42
626.41
726.16
753.06
growth rate 3.0% 0.2% 10.3% 4.3% -2.5% -6.0% 7.4% 15.3% 15.9% 3.7%
Common Shares 31.00
31.00
31.00
31.00
31.00
31.00
31.00
31.00
31.00
31.00
31.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Nov '07 Nov '08 Nov '09 Nov '10 Nov '11 Nov '12 Nov '13 Nov '14 Nov '15 Nov '16 Nov '17
Capital Expenditures 87.86
92.30
83.10
68.00
83.00
113.00
116.00
122.15
121.67
4.02
19.66
growth rate 5.1% -10.0% -18.2% 22.1% 36.1% 2.7% 5.3% -0.4% -96.7% 388.4%
Cash Dividends 0.00
0.00
0.00
0.00
0.00
0.00
28.91
29.94
32.41
92.87
34.89
growth rate 3.6% 8.3% 186.5% -62.4%
Cash From OA 54.11
165.30
117.50
160.00
130.00
174.00
146.68
158.29
203.78
173.49
219.16
growth rate 205.5% -28.9% 36.2% -18.8% 33.9% -15.7% 7.9% 28.7% -14.9% 26.3%
FCF per Share -1.07
-1.07
0.99
2.76
1.39
1.74
1.15
0.90
2.47
2.48
2.28
growth rate 0.0% 100.0% 178.8% -49.6% 25.2% -33.9% -21.7% 174.4% 0.4% -8.1%
FCF -34.00
62.00
31.00
87.00
44.00
55.00
28.00
33.00
78.00
63.00
103.00
growth rate 100.0% -50.0% 180.7% -49.4% 25.0% -49.1% 17.9% 136.4% -19.2% 63.5%
Income Statement Nov '07 Nov '08 Nov '09 Nov '10 Nov '11 Nov '12 Nov '13 Nov '14 Nov '15 Nov '16 Nov '17
Sales 957.70
1,060.10
1,000.20
1,025.00
1,095.00
1,219.00
1,265.93
1,290.02
1,282.91
1,375.46
1,348.26
growth rate 10.7% -5.7% 2.5% 6.8% 11.3% 3.9% 1.9% -0.6% 7.2% -2.0%
Op.Income 61.00
60.40
47.00
54.00
68.00
140.17
139.74
141.18
176.21
172.27
growth rate -1.0% -22.2% 14.9% 25.9% 106.1% -0.3% 1.0% 24.8% -2.2%
IBT 17.30
20.10
60.70
72.50
98.50
98.75
99.35
147.35
146.94
145.49
growth rate 16.2% 202.0% 19.4% 35.9% 0.3% 0.6% 48.3% -0.3% -1.0%
Net Income 4.50
7.00
47.00
54.00
68.00
62.16
66.34
104.22
121.64
100.89
growth rate 55.6% 571.4% 14.9% 25.9% -8.6% 6.7% 57.1% 16.7% -17.1%
EPS -0.04
0.02
0.18
1.38
1.61
1.98
1.98
2.11
3.32
3.87
3.21
growth rate 100.0% 800.0% 666.7% 16.7% 23.0% 0.0% 6.6% 57.4% 16.6% -17.1%
Gross Profit 274.20
293.30
265.30
306.00
321.00
361.00
364.22
356.12
373.77
431.75
413.84
growth rate 7.0% -9.6% 15.3% 4.9% 12.5% 0.9% -2.2% 5.0% 15.5% -4.2%

Quarterly Statements

Item Name Aug '17 Nov '17 Feb '18 May '18 Aug '18
Earnings BIT 46.29
53.79
17.37
37.27
38.58
growth rate 16.2% -67.7% 114.5% 3.5%
Balance Sheet Aug '17 Nov '17 Feb '18 May '18 Aug '18
Acct.Receivable 249.79
268.16
246.96
253.19
271.81
growth rate 7.4% -7.9% 2.5% 7.4%
Acct.Payable 119.11
176.30
130.61
131.59
152.06
growth rate 48.0% -25.9% 0.8% 15.6%
Cur.Assets 544.02
715.21
708.25
546.73
559.42
growth rate 31.5% -1.0% -22.8% 2.3%
Total Assets 2,255.88
2,444.10
2,388.48
2,244.57
2,651.06
growth rate 8.3% -2.3% -6.0% 18.1%
Cash 119.86
287.04
275.50
93.52
86.94
growth rate 139.5% -4.0% -66.1% -7.0%
Inventory 163.45
148.36
168.01
180.66
176.25
growth rate -9.2% 13.3% 7.5% -2.4%
Cur.Liabilities 751.57
673.34
636.48
490.27
752.54
growth rate -10.4% -5.5% -23.0% 53.5%
Liabilities 1,505.21
1,654.57
1,564.56
1,421.65
1,826.46
growth rate 9.9% -5.4% -9.1% 28.5%
LT Debt 445.30
673.86
681.05
681.15
751.13
growth rate 51.3% 1.1% 0.0% 10.3%
Equity 714.64
753.06
787.21
804.45
806.19
growth rate 5.4% 4.5% 2.2% 0.2%
Common Shares 31.40
31.40
31.40
31.40
31.40
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Aug '17 Nov '17 Feb '18 May '18 Aug '18
Capital Expenditures 18.61
-29.78
9.18
13.66
18.21
growth rate -100.0% 100.0% 48.9% 33.3%
Cash Dividends 1.92
1.92
34.54
34.54
growth rate 0.0% 1,699.9% 0.0%
Cash From OA 69.67
116.21
-2.32
8.07
62.10
growth rate 66.8% -100.0% 100.0% 669.6%
FCF 51.06
86.43
-11.50
-5.59
43.89
growth rate 69.3% -100.0% 0.0% 100.0%
Income Statement Aug '17 Nov '17 Feb '18 May '18 Aug '18
Sales 331.47
374.44
290.37
332.64
353.60
growth rate 13.0% -22.5% 14.6% 6.3%
Op.Income 46.29
53.79
17.37
37.27
38.58
growth rate 16.2% -67.7% 114.5% 3.5%
IBT 37.53
52.92
7.91
27.71
26.36
growth rate 41.0% -85.1% 250.5% -4.9%
Net Income 25.60
37.83
48.66
18.77
18.42
growth rate 47.8% 28.6% -61.4% -1.9%
EPS
growth rate
Gross Profit 99.03
122.35
81.12
97.33
97.86
growth rate 23.6% -33.7% 20.0% 0.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (59.14)

YOY Growth Grade:

D (42.58)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 15.68 15.48 14.16
EPS / Growth 25.8% 3.94 28.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 6.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 6.9% 20.3% 20.3%
Future PE 13.72 15.17 23.45
Future EPS 7.64 24.88 24.88
Value Price
MOS %
25.91
-57.5%
93.30
53.2%
144.18
136.7%
MOS Price 12.96 46.65 72.09
IRT 10.39 6.95 6.95

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.